Eritrea vs Lao People's Democratic Republic: Average cost of multi drug-resistant tuberculosis treatment
Eritrea
793 constant 2022 US$
in 2024
Lao People's Democratic Republic
756 constant 2022 US$
in 2024
Eritrea rank
62nd
Lao People's Democratic Republic rank
64th
Average cost of multi drug-resistant tuberculosis treatment over time
- Eritrea
- Lao People's Democratic Republic
How they compare
Eritrea currently reports 793 constant 2022 US$ against 756 constant 2022 US$ in Lao People's Democratic Republic, a difference of 37 constant 2022 US$.
Across all 7 years both countries report, Eritrea has been ahead every year.
Eritrea ranks 62nd and Lao People's Democratic Republic ranks 64th of 92 countries.
Eritrea has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Eritrea | Lao People's Democratic Republic | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2,666 constant 2022 US$ | 1,000 constant 2022 US$ | 1,666 constant 2022 US$ | Eritrea |
| 2020s | 3,106 constant 2022 US$ | 951.2 constant 2022 US$ | 2,155 constant 2022 US$ | Eritrea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average cost of multi drug-resistant tuberculosis treatment, Eritrea or Lao People's Democratic Republic?
- Eritrea, at 793 constant 2022 US$ against 756 constant 2022 US$ in Lao People's Democratic Republic as of 2024.
- What is the difference in average cost of multi drug-resistant tuberculosis treatment between Eritrea and Lao People's Democratic Republic?
- 37 constant 2022 US$, with Eritrea ahead.
- How many years of comparable data are there for Eritrea and Lao People's Democratic Republic?
- 7 years are reported by both, from 2018 to 2024.
- How do Eritrea and Lao People's Democratic Republic rank globally for average cost of multi drug-resistant tuberculosis treatment?
- Eritrea ranks 62nd and Lao People's Democratic Republic ranks 64th of 92 countries.
- Where does this data come from?
- WHO (2025) – with minor processing by Our World in Data, published as Average cost of multi drug-resistant tuberculosis treatment. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Average cost of drugs spent per patient starting multidrug-resistant tuberculosis treatment, excluding buffer stock.